EKSO Earnings History
Ekso Bionics Holdings, Inc. (EKSO) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $28.6M, listed on NASDAQ, employing roughly 61 people, carrying a beta of 0.78 to the broader market. Ekso Bionics Holdings, Inc. Led by Scott G. Davis, public since 2014-01-17.
Ekso Bionics Holdings, Inc. has beat EPS estimates in 1 of the last 6 quarters.
| Date | EPS Est. | EPS Actual | Surprise | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 27, 2026 | -0.06 | N/A | N/A | $2.5M | N/A |
| Apr 28, 2026 | -0.03 | -2.04 | N/A | $4.3M | $2.1M |
| Feb 23, 2026 | -0.08 | -1.56 | N/A | $5.0M | $3.1M |
| Oct 28, 2025 | -0.99 | -0.54 | N/A | $5.0M | $4.2M |
| Jul 28, 2025 | -1.20 | -1.24 | N/A | $4.1M | $2.1M |
| May 5, 2025 | -1.65 | -1.80 | N/A | $5.5M | $3.4M |
What EKSO's Earnings History Tells Options Traders
Ekso Bionics Holdings, Inc. has missed estimates more often than it has beat them (only 1 beats in 6 reports). Names with poor beat-rate history typically carry richer downside skew going into earnings and produce larger post-event moves on misses, conditions where put-spread or long-vol structures may carry edge over premium-selling. Beat rate is one input to event-driven sizing; pair it with the implied-vs-realized volatility view, the current IV rank, and the put-call skew going into the print. Surprise magnitude matters as much as direction - an in-line beat with conservative guidance can produce a larger negative move than a missed quarter with raised forward guidance. The earnings table above shows the most recent six reported quarters; for the full multi-year history including revenue growth trajectory and EPS guidance trends, the per-ticker fundamentals view aggregates the underlying GAAP filings.
How Earnings Drive EKSO Options Pricing
Earnings events are the largest single driver of single-name implied volatility in equity options markets. Pre-event, IV inflates over the two-to-three week run-up as the binary uncertainty of the print compounds; the IV rank typically peaks the day before the announcement. Post-event, IV crushes back toward the realized-volatility baseline as uncertainty resolves. The magnitude of the crush depends on how stretched pre-event IV was relative to the eventual realized move - an oversized pre-event IV with an undersized realized move produces the cleanest premium-selling outcome, while a stretched IV that still under-prices a tail move on the print produces the cleanest long-vol outcome.
The catalyst calendar for EKSO matters beyond the headline EPS surprise. Forward guidance revisions, capital-allocation changes (dividend hikes, buyback authorizations, M&A announcements), and segment-level performance discussions can drive larger post-event moves than the headline beat or miss. Pair the earnings beat-rate read above with the upcoming-event calendar and the IV-rank view to size pre-event and post-event positioning; for short-vol structures the goal is to be long premium-rich and to harvest the IV crush, while for long-vol structures the goal is to own gamma cheap into a regime where the realized move is likely to exceed the implied move.